Kenneth Hughes
Chief Operating Officer at MICROBIX BIOSYSTEMS INC.
Net worth: 106 015 $ as of 2024-05-30
Kenneth Hughes active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MICROBIX BIOSYSTEMS INC. | Chief Operating Officer | 2019-06-02 | - |
| Roker Biotechnologies, Inc. | Founder | 2009-12-31 | - |
| President | 2009-12-31 | - |
Career history of Kenneth Hughes
Former positions of Kenneth Hughes
| Companies | Position | Start | End |
|---|---|---|---|
| Itp Biomedica Corp. | Chief Executive Officer | 2013-12-31 | 2018-12-31 |
| President | 2013-12-31 | 2018-12-31 | |
Innovative Medicines Canada
 Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Chief Tech/Sci/R&D Officer | 2010-12-31 | 2012-12-31 |
| MICROBIX BIOSYSTEMS INC. | Chief Tech/Sci/R&D Officer | 1994-12-31 | 2009-12-31 |
PlantForm Corp.
 PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Founder | 2007-12-31 | - |
Hemosol Corp. /Old/
 Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Corporate Officer/Principal | - | - |
Training of Kenneth Hughes
| University of London | Doctorate Degree |
| The University of Sheffield | Undergraduate Degree |
Statistics
International
| Canada | 7 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| President | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MICROBIX BIOSYSTEMS INC. | Health Technology |
| Private companies | 5 |
|---|---|
Hemosol Corp. /Old/
Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin. | Health Technology |
Innovative Medicines Canada
Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
PlantForm Corp.
PlantForm Corp. Pharmaceuticals: MajorHealth Technology PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada. | Health Technology |
| Itp Biomedica Corp. | |
| Roker Biotechnologies, Inc. |
- Stock Market
- Insiders
- Kenneth Hughes
- Experience
